index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques Accéder directement au contenu

Dernières publications

Chiffres clés

55 Publications avec texte intégral

Open Access

46 %

Mots clés

Cardiomyopathy Chronicity BAFF Ferrites Immune regulation Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Experimental autoimmune myasthenia gravis Acetylcholine receptor antibodies Disease susceptibility Neuromuscular junction Early-onset myasthenia gravis Myasthenia Gravis MG Exercise Transcriptome Clinical cell transplantation Myasthenia gravis MYB Etiology Macrophages DICER Inflammation Ectopic germinal centers B cells Th17 cells Inflammatory cytokines Immune response Long-term follow-up Glucocorticoids Gd T cells Immunotherapy COVID-19 Myoblasts Max Auto-immunité Chemokines MiR-125 PBMC Genetic associations Complete Freund's adjuvant CXCL13-CXCR5 Acetylcholine receptor Thymus Experimental mouse models Acetylcholine receptors Gender CTCF Germinal center Genetics Adaptive immunity Innate immunity MG patients Centres germinatifs ectopiques Anticorps monoclonal FMR1 Immunology and Microbiology Section Germinal centers Chemokine Endogenous nucleic acids Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Autoimmunity AChR antibodies Interferon type I Il-23 Thymic epithelial cells Interleukine-23 Lamin A/C nuclei Mass cytometry CyTOF Fragile X syndromes CD31 LMNA Human myoblasts Chronic inflammation Experimental autoimmune myasthenia gravis EAMG Heart failure Thymoma Interferon type-I Antimir-150 Acides nucléiques endogènes Animal models COX2 Myasthénie grave Interferon de type I Interleukin 23 Cellules th17 Conduction disease Quality of life CCL21 Interferon IFN Autoimmune diseases Experimental models Immunity Cytokines Autoimmune disease Interferon M3243AG Interféron de type I Interferon-β MiR-7 Interferonopathy Maladie auto-immune